Association of Lutein, Zeaxanthin and Brilliant Blue in Chromovitrectomy

Last updated: March 15, 2016
Sponsor: Federal University of São Paulo
Overall Status: Completed

Phase

3

Condition

Diabetic Vitreous Hemorrhage

Diabetic Retinopathy

Macular Degeneration

Treatment

N/A

Clinical Study ID

NCT01627977
LUT-RET
  • Ages 18-90
  • All Genders

Study Summary

The aim of this study is to test the efficacy of the combination of dye Lutein, Zeaxanthin and brilliant blue to stain the internal limiting membrane as well as the epiretinal membranes during the Vitrectomy surgery.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients over 18 years, both gender

  • Diagnosis of epiretinal membrane OR macular hole OR proliferative diabetic retinopathy

  • Indication of surgical treatment for removal of the epiretinal membrane

Exclusion

Exclusion Criteria:

  • Any history of eye disease

  • glaucoma

  • Eye infection affecting any structure provided eye

Study Design

Total Participants: 18
Study Start date:
October 01, 2012
Estimated Completion Date:
March 31, 2014

Study Description

Twenty five patients with epiretinal membrane, macular hole or proliferative diabetic retinopathy and indication of vitrectomy surgery will be selected to participate in this study.

Connect with a study center

  • Depto. of Ophthalmology - Hospital São Paulo - UNIFESP

    São Paulo, SP 04023-062
    Brazil

    Site Not Available

  • Depto. of Ophthalmology - Hospital São Paulo - UNIFESP

    São Paulo, SP 04023-062
    Brazil

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.